Surgical Science Sweden Stock EBITDA
| SUSRF Stock | USD 12.75 0.00 0.00% |
Surgical Science Sweden fundamentals help investors to digest information that contributes to Surgical Science's financial success or failures. It also enables traders to predict the movement of Surgical Pink Sheet. The fundamental analysis module provides a way to measure Surgical Science's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgical Science pink sheet.
Surgical |
Surgical Science Sweden Company EBITDA Analysis
Surgical Science's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Surgical Science EBITDA | 122.27 M |
Most of Surgical Science's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Surgical Science Sweden reported earnings before interest,tax, depreciation and amortization of 122.27 M. This is 86.07% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The ebitda for all United States stocks is 96.86% higher than that of the company.
Surgical EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgical Science's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics of similar companies.Surgical Science is currently under evaluation in ebitda category among its peers.
Surgical Fundamentals
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Current Valuation | 743.09 M | |||
| Shares Outstanding | 50.8 M | |||
| Shares Owned By Insiders | 32.75 % | |||
| Shares Owned By Institutions | 52.03 % | |||
| Price To Earning | 73.41 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 366.78 M | |||
| Gross Profit | 265.94 M | |||
| EBITDA | 122.27 M | |||
| Net Income | 86.25 M | |||
| Total Debt | 29.42 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 2.66 X | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 0.28 X | |||
| Number Of Employees | 233 | |||
| Beta | 0.94 | |||
| Market Capitalization | 833.72 M | |||
| Total Asset | 3.98 B | |||
| Z Score | 16.8 | |||
| Net Asset | 3.98 B |
About Surgical Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgical Science Sweden's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science Sweden based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.